| Literature DB >> 34337501 |
Thomas Bjoersum-Meyer1,2, Lasse Kaalby1,2, Lars Lund3, Peter Christensen4, Marianne S Jakobsen5, Gunnar Baatrup1,2, Niels Qvist1,2, Mark Ellebaek1,2.
Abstract
CONTEXT: Long-term urinary and sexual outcomes after repair of anorectal malformations (ARMs) are currently affected by concomitant malformations of the urinary tract and genitalia, sacral anomalies, and the surgical approach. However, the overall prevalence of urinary and sexual dysfunction remains unclear.Entities:
Keywords: Anorectal malformation; Paediatric surgery; Sexual outcome; Urinary outcome
Year: 2021 PMID: 34337501 PMCID: PMC8317805 DOI: 10.1016/j.euros.2021.01.007
Source DB: PubMed Journal: Eur Urol Open Sci ISSN: 2666-1683
Translation of the Krickenbeck classification to the Wingspread classification
| Krickenbeck classification | Wingspread classification | |||
|---|---|---|---|---|
| Low | Intermediate | High | ||
| Males | Rectoperineal fistula | X | ||
| Rectourethral bulbar fistula | X | |||
| Rectourethral prostatic fistula | X | |||
| Rectobladderneck fistula | X | |||
| Imperforate anus without fistula | X | |||
| Females | Rectoperineal fistula | X | ||
| Rectovestibular fistula | X | |||
| Imperforated anus without fistula | X | |||
| Rectal atresia | X | |||
Fig. 1PRISMA flow diagram of the study selection process.
Summary of the studies included in the review
| Study | Study design | Gender | Outcomes | NOS | AAs (%) | ARM severity | ARM surgery | Questionnaire | Age (yr) | Sample ( | Control group | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| S | C | O | T | UG | SP | High | Int. | Low | |||||||||
| Trovalusci 2020, Italy | CSS, MC | Male | ED, EJD | 2 | 0 | 1 | 3 | NR | NR | Yes | Yes | Yes | PSARP, LAARP | IIEF | 26 (18–41) | 25 | No |
| Bjørsum-Meyer 2020, Denmark | CSS, SC | Both | SD, ED, BR | 1 | 0 | 2 | 3 | 34.6 | 50.0 | Yes | Yes | Yes | PSARP 10 Perineal 9 Dilatation 4 APPT 2 Cutback 1 | FSFI, IIEF | 24 (18–32) | 26 | No |
| Eleuteri 2019, Italy | CSS, SC | Male | ED, EJD | 1 | 0 | 1 | 2 | NR | NR | NR | NR | NR | NR | AIMAR | 28.8 ± 10.6 | 12 | No |
| Witvliet 2018, The Netherlands | CSS, MC | Both | SD, ED | 3 | 0 | 2 | 5 | 21.6 | NR | Yes | No | Yes | PSARP, anoplasty, ASARP, Rehbein, PSARVUP, others | FSFI, IIEF | >18 | 37 | No |
| Kyrklund 2016, Finland | CSS, SC | Both | LUTS | 2 | 0 | 1 | 3 | NR | 33.3 | No | Yes | Yes | PSARP/ ASARP | DPSS | >12 | 39 | No |
| Kyrklund 2016, Finland | CSS, SC | Male | ED, EJD | 2 | 0 | 1 | 3 | 12.2 | 19.5 | Yes | Yes | Yes | PSARP 20 ASARP 10 Cutback/dilatation 11 | Erection Hardness Score | 21 (16–29) | 41 | Yes |
| Hondel 2015, The Netherlands | CSS, MC | Both | SD, ED | 3 | 0 | 2 | 5 | 29 | NR | Yes | Yes | Yes | APPT, PSARP, perineal, others | FSFI, IIEF | >18 | 63 | No |
| Borg 2013, Sweden | PS, SC | Both | LUTS | 3 | 0 | 3 | 6 | NR | NR | Yes | Yes | Yes | PSARP | Designed | 10 | 24 | No |
| Schmidt 2012, Germany | CSS, MC | Both | EJD, BR | 1 | 0 | 1 | 2 | NR | NR | Yes | Yes | Yes | NR | NS | 19–35 | 55 | No |
| Schmidt 2012, Germany | CSS, MC | Male | NBD | 1 | 0 | 1 | 2 | NR | NR | Yes | Yes | Yes | NR | Interview | 18–56 | 32 | No |
| Grano 2011, Italy | PS, SC | Both | UI | 1 | 0 | 1 | 2 | NR | 16.7 | Yes | Yes | Yes | NR | HAQL | 17–49 | 36 | No |
| Davies 2010, USA | CSS, SC | Both | UI, SD, ED, EJD, BR | 3 | 0 | 0 | 3 | NR | 43.8 | Yes | Yes | Yes | NR | ICS-male | 25.6 (18–46) | 74 | No |
| Iwai 2007, Japan | CSS, SC | Both | ED, EJD, BR | 1 | 0 | 1 | 2 | 10.3 | 3.6 | Yes | Yes | Yes | APPT/ perineoplasty | NR | 26.3 (20–40) | 29 | No |
| Konuma 2006, Japan | CSS, SC | Male | ED, EJD, NBD, BR | 1 | 0 | 1 | 2 | 17.7 | 35.3 | Yes | Yes | No | APPT, SP, ASP | Interview | 24 (20–29) | 17 | No |
| Rintala 1999, Finland | CSS, SC | Male | UI | 1 | 0 | 2 | 3 | NR | 44.4 | Yes | No | No | ASP, PSARP | NR | 10–22 | 36 | No |
| Hassink 1993, The Netherlands | CSS, SC | Both | UI | 1 | 1 | 0 | 2 | 45.0 | 48.0 | Yes | No | No | APPT, ASP, perineal | NR | 26.0 (18.1–56.9) | 58 | No |
| Rintala 1992, Finland | CSS, SC | Both | UI, BR | 2 | 0 | 1 | 3 | NR | NR | No | No | Yes | Dilatations, cutback, pull-through | Unspecified questionnaire | 35.2 ± 4.1 | 83 | Yes |
CSS = cross-sectional study; PS = prospective study; MC = multicentre; SC = single-centre; ED = erectile dysfunction; EJD = ejaculatory dysfunction; SD = sexual dysfunction; BR = birth rate; LUTS = lower urinary tract symptoms; NBD = neurogenic bladder dysfunction; UI = urinary incontinence; NOS = Newcastle-Ottawa Scale (S = selection; C = comparability; O = outcome; T = total score); AAs = associated anomalies (UG = urogenital; SP = spinal); NR = not reported; ARM = anorectal malformation; PSARP = posterior sagittal anorectoplasty; LAARP = laparoscopic assisted anorectal pull-through; APPT = abdominoperineal pull-through; ASARP = anterior sagittal anorectoplasty; PSARVUP = posterior sagittal anorectal vaginal urethraplasty; SP = sacroperineal dissection; ASP = abdominosacroperineal dissection; IIEF = International Index of Erectile Function; FSFI = Female Sexual Function Index; AIMAR = Italian Association for Anorectal Malformations; DPSS = Danish Prostatic Symptom Score; HAQL = Hirschsprung Disease/Anorectal Malformation Quality of Life Questionnaire; ICS = International Continence Society.
Fig. 2Forest plots of the reported prevalence of urinary incontinence, lower urinary tract symptoms (LUTS)/neurogenic bladder dysfunction (NBD), and birth rate for patients with anorectal malformations.
ES = effect size; CI = confidence interval.
Fig. 3Forest plots of the reported prevalence of sexual dysfunction, erectile dysfunction, and ejaculatory dysfunction for patients with anorectal malformations.
ES = effect size; CI = confidence interval.